Table 2 Demographics of primary dogs in a clinical field study investigating the safety and efficacy of Simparica Trio™
Category | Treatment group | ||
|---|---|---|---|
Simparica Trio™ (n = 167) | Afoxolaner (n = 84) | Total (n = 251) | |
No. of females (%) | 78 (46.7) | 41 (48.8) | 119 (47.4) |
No. of males (%) | 89 (53.3) | 43 (51.2) | 132 (52.6) |
No. neutered (%) | 99 (59.3) | 60 (71.4) | 159 (63.3) |
No. not neutered (%) | 68 (40.7) | 24 (28.6) | 92 (36.7) |
Mean initial age in years (range) | 5.1 (0.2–17.0) | 4.9 (0.2–14.0) | 5.0 (0.2–17.0) |
Pure-bred/mixed breed % | 50.3/49.7 | 48.8/50.2 | 49.8/50.2 |
No. short hair length (%) | 91 (54.5) | 50 (59.5) | 141 (56.2) |
No. medium hair length (%) | 56 (33.5) | 27 (32.1) | 83 (33.1) |
No. long hair length (%) | 20 (12.0) | 7 (8.3) | 27 (10.8) |
No. indoors and outdoors (%) | 65 (38.9) | 39 (46.4) | 104 (41.4) |
No. mostly indoors (%) | 90 (53.9) | 43 (51.2) | 133 (53.0) |
No. mostly outdoors (%) | 12 (7.2) | 2 (2.4) | 14 (5.6) |